Anticancer cellular immunotherapies derived from umbilical cord blood-Reference-Cited by-同舟云学术

Anticancer cellular immunotherapies derived from umbilical cord blood

Published:2017-11-09 Issue:2 Volume:18 Page:121-134
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Balassa Katalin¹²,Rocha Vanderson¹²³

Affiliation:

1. Department of Clinical Haematology, Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK

2. NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK

3. Department of Haematology, University of Sao Paulo, Sao Paulo, Brazil

Funder

NHS Blood and Transplant

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1402002

Reference128 articles.

1. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors

2. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

3. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

4. Advances in umbilical cord blood manipulation—from niche to bedside

5. Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies;Advanced Science;2023-10-31

2. How can Cytokine-induced killer cells overcome CAR-T cell limits;Frontiers in Immunology;2023-08-22

3. Cord blood-derived CD19-specific chimeric antigen receptor T cells: an off-the-shelf promising therapeutic option for treatment of diffuse large B-cell lymphoma;Frontiers in Immunology;2023-06-27

4. Induction of Angiogenesis by Genetically Modified Human Umbilical Cord Blood Mononuclear Cells;International Journal of Molecular Sciences;2023-02-23

5. Natural Killer Cells for Cancer Immunotherapy: Opportunities and Challenges;Natural Killer Cells - Lessons and Challenges;2023-02-22